Emerging Diseases News

A 15-day course of Paxlovid demonstrated no significant benefit for patients with post-acute sequelae of SARS-CoV-2 infection, according to data published in JAMA Internal Medicine.

A Florida hospital doubled the size of its infection prevention staff over a 4-year period and saw a substantial decrease in hospital-related infections, researchers reported at the Association for Professionals in Infection Control and Epidemiology annual meeting.

Installation of a stethoscope disinfection device improved hand hygiene compliance among health care workers at an urgent care clinic and ED, researchers reported.

Patients with long COVID symptoms demonstrate elevated levels of several inflammatory molecules — findings that could have important implications in both rheumatology and the search for a potential treatment for long COVID.

A dairy farm worker in Colorado became the fourth person to test positive for avian influenza in the ongoing outbreak affecting dairy cows in the United States, the CDC announced Wednesday.

HHS announced that it will give Moderna around $176 million to accelerate the development of a messenger RNA-based pandemic influenza vaccine amid an ongoing outbreak of avian influenza.

Avian influenza continues to be detected among birds and dairy cows in the United States, raising questions about how to control the more than 2-year-old outbreak.

The CDC on Thursday recommended updated COVID-19 vaccines for the 2024-2025 respiratory season, and a newly approved 21-valent pneumococcal conjugate vaccine for adults.

Patients receiving infectious diseases consultation over the past decade were increasingly complex, generally sicker and more likely to die soon after a consultation was performed.

Children hospitalized with SARS-CoV-2 or an inflammatory syndrome associated with SARS-CoV-2 infection who experience severe neurological manifestations may be at a higher risk for long-term impairment, a study found.